Загрузка...
Treating advanced kidney cancer—miles to go before we sleep
A randomized phase III trial comparing pazopanib with sunitinib in patients with advanced clear cell renal cell carcinoma showed that although progression-free survival and overall survival were similar, pazopanib was better tolerated. Recent advances in genomics and metabolomics have provided novel...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4174460/ https://ncbi.nlm.nih.gov/pubmed/24129349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.183 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|